Assembly Biosciences, Inc. (ASMB)
28.20
-0.10
(-0.35%)
USD |
NASDAQ |
Mar 13, 11:30
Assembly Biosciences EPS Diluted (Quarterly) : -0.7249 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.742 |
| CorMedix, Inc. | 0.1493 |
| Supernus Pharmaceuticals, Inc. | -0.0716 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.196M |
| Revenue (Quarterly) | 10.79M |
| Total Expenses (Quarterly) | 19.98M |
| Enterprise Value | 217.82M |
| Gross Profit Margin (Quarterly) | 99.70% |
| Profit Margin (Quarterly) | -85.24% |
| Earnings Yield | -17.03% |
| Normalized Earnings Yield | -17.03 |